Toggle navigation
Home
Search
Services
Blog
Contact
About
Vaccinotherapy for Recurrent Herpes Simplex Keratitis
Neumann, Ron
Massachusetts Eye and Ear Infirmary, Boston, MA, United States
Search grants from Ron Neumann
Search grants from Massachusetts Eye and Ear Infirmary
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Preclinical development of a chemopreventive agent, 4-methylumbelliferone(4-MU) HHSN2512015000361 TORFP: 2018-E07 PP: 9/17/18 to 9/16/19
Migration and function of Th17 cells in the gut
Tgf 2-2 controls p19Arf during eye development
Specific target of NO-mediated damage in M.tuberculosis
Presynaptic Proteins in Transmitter Release & Synaptic Plasticity
Recently added grants:
Ubiquitin-dependent mitochondrial quality control
Mechanism of nucleus-to-plastid light signaling in controlling plastid transcription
The ion channel TRPA1 is required for suppression of inflammation in sepsis
Small RNAs and telomere biology
PED Screen: Pediatric Sepsis EHR Registry, Clinical Outcomes, and Predictive Model
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Fogarty International Center (FIC)
Type
International Research Fellowships (FIC) (F05)
Project #
5F05TW004420-02
Application #
3022016
Study Section
International and Cooperative Projects 1 Study Section (ICP)
Project Start
1991-09-28
Project End
Budget Start
1991-09-28
Budget End
1992-09-27
Support Year
2
Fiscal Year
1991
Total Cost
Indirect Cost
Institution
Name
Massachusetts Eye and Ear Infirmary
Department
Type
DUNS #
073825945
City
Boston
State
MA
Country
United States
Zip Code
02114
Related projects
NIH 1991
F05 TW
Vaccinotherapy for Recurrent Herpes Simplex Keratitis
Neumann, Ron / Massachusetts Eye and Ear Infirmary
NIH 1990
F05 TW
Vaccinotherapy for Recurrent Herpes Simplex Keratitis
Neumann, Ron / Massachusetts Eye and Ear Infirmary
Comments
Be the first to comment on Ron Neumann's grant